01
Fund
Non-dilutive capital strategy, SBIR/STTR, federal opportunities and investor readiness tied to the technical and commercial risks your technology must retire.
Deep-Tech Capital & Commercialization
Turn difficult technology into a fundable, investable and commercially viable business.
ForgeBridge aligns technology, capital and commercialization strategy—from SBIR/STTR and non-dilutive funding through partnerships, investor readiness and market execution.
ForgeBridge / Strategy System
Science
What is possible
Strategy
What is fundable
Execution
What becomes commercial
We build the bridge.
50+
Competitive federal awards
$30M+
Directly led
$85M+
Non-dilutive capital supported
NSF
External reviewer
Experience statements describe prior work and independent reviewer service; they do not imply endorsement by NSF or any federal agency.
The operating thesis
Funding strategy and commercial strategy are one system.
Sophisticated capital providers evaluate technology, team, market and execution path together. ForgeBridge does the same.
We help technical founders determine what to fund, who will buy it, what evidence is missing, which capital fits and what should happen next—before valuable time and submission opportunities are spent.
The work
Fund. Commercialize. Communicate.
One senior team connects the decisions that determine whether difficult science and engineering become a durable commercial enterprise.
02
Commercialize
Application prioritization, customer discovery, pilot strategy, partnerships and business development for technically complex products.
03
Communicate
Investor, proposal, market and customer narratives that make sophisticated technology understandable without diluting its technical substance.
Start here
Capital & Commercialization Diagnostic
$6,500 fixed fee
7–10 business days
A senior-level assessment of your technology, funding options, commercialization pathway and immediate priorities.
Technology readiness & R&D risk
Capital pathways and sequencing
Initial application and market
Team, partner and communications gaps
You leave with a concise Capital & Commercialization Roadmap: now, next 90 days, six months and twelve months.
Request an AssessmentSenior team, integrated delivery
Strategy becomes actionable when it is clear.
Steven C. Arzberger, PhD
Technology · Capital · Commercialization
Steven leads technical-commercial diligence, capital strategy, federal funding, strategic partnerships and executive engagement.
Jenny Daniel
Market Strategy · Communications · Client Experience
Jenny develops the market, investor and customer communication architecture that makes complex value clear and compelling.
Who we work with
For companies building what is hard to build.
Advanced materialsEnergy & storageAerospaceSpaceDefense / dual-useIndustrial technologyClean technologyWater & environmentMedical devicesScientific instrumentation
Good technology is only the beginning
Find the capital and commercial path your technology deserves.
Bring the technical truth. We will help determine the strategy, evidence and execution required to turn it into enterprise value.